Viroloxía e Patoxénese ‘VIP’
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (6)
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
-
Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters
International Journal of Antimicrobial Agents, Vol. 63, Núm. 1
2023
-
A Randomized Trial of Dolutegravir Plus Darunavir/ Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes
Open Forum Infectious Diseases, Vol. 10, Núm. 11
2022
-
Determinants of long-term survival in late HIV presenters: The prospective PISCIS cohort study
eClinicalMedicine, Vol. 52
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836
-
Progress in the quality of care for newly diagnosed people with HIV in Spain (2004–2019)
Antiviral Therapy, Vol. 27, Núm. 4